Trials / Conditions / Cerebrospinal Fluid Leak

Cerebrospinal Fluid Leak

15 registered clinical trials studyying Cerebrospinal Fluid Leak — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Safety and Efficacy Evaluation of ArtiFix® Sealant Graft in Subjects Requiring Dural Repair Following Neurosur NCT07092267	Nurami Medical Ltd	N/A
Not Yet Recruiting	Effect of Spinal Needle Type on Optic Nerve Sheath Diameter NCT06497634	Bagcilar Training and Research Hospital	N/A
Completed	Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surg NCT04086550	Polyganics BV	N/A
Completed	Suturable DuraGen™ PMCF Study NCT04923867	Integra LifeSciences Corporation	—
Withdrawn	Acetazolamide for the Prevention of Post Operative CSF Leak NCT04351061	University of Miami	Phase 2
Completed	A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Comme NCT04145544	Nurami Medical Ltd	N/A
Unknown	The Efficacy and Safety of a Latest Dural Substitute NCT04490629	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Completed	Post-market Assessment of Biodesign Dural Repair Grafts NCT04057157	Cook Research Incorporated	—
Completed	Perioperative CSF Leak Management - an Opinion Study NCT04124523	University Hospital, Montpellier	—
Completed	Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial S NCT03566602	Polyganics BV	N/A
Withdrawn	Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics NCT03181464	Washington University School of Medicine	Phase 4
Completed	Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery NCT02891070	Baxter Healthcare Corporation	Phase 3
Withdrawn	Acetazolamide to Prevent Post Operative CSF Leak NCT02902133	University of Miami	Phase 2
Unknown	Mobilisation Algorithm After Incidental Durotomy NCT02927782	Balgrist University Hospital	N/A
Completed	The EVICEL® Neurosurgery Phase III Study NCT02457546	Ethicon, Inc.	Phase 3